Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models

References

• Krismer F, Wenning GK. Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol. 2017;13(4):232–243.
   PubMed Web of Science ®Google Scholar
• Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol. 1998;44(3):415–422.
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Yoshimoto M, Tsuji S, et al. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 1998;249:180–182.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Laszlo L, Kovacs J, et al. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis. 2004;17(2):155–162.
   PubMed Web of Science ®Google Scholar
• Orosz F, Kovacs GG, Lehotzky A, et al. TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments. Biol Cell. 2004;96(9):701–711.
   PubMed Web of Science ®Google Scholar
• Lindersson E, Lundvig D, Petersen C, et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem. 2005;280:5703–5715.
   PubMed Web of Science ®Google Scholar
• Miller DW, Johnson JM, Solano SM, et al. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm (Vienna). 2005;112:1613–1624.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Okuizumi K, Ikeuchi T, et al. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. 2001;102:188–190.
   PubMed Web of Science ®Google Scholar
• Asi YT, Simpson JE, Heath PR, et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia. 2014;62(6):964–970.
   PubMed Web of Science ®Google Scholar
• Djelloul M, Holmqvist S, Boza-Serrano A, et al. Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Reports. 2015;5(2):174–184.
   PubMed Web of Science ®Google Scholar
• Mavroeidi P, Arvanitaki F, Karakitsou AK, et al. Endogenous oligodendroglial alpha-synuclein and TPPP/p25alpha orchestrate alpha-synuclein pathology in experimental multiple system atrophy models. Acta Neuropathol. 2019;138(3):415–441.
   PubMed Web of Science ®Google Scholar
• Kaji S, Maki T, Kinoshita H, et al. Pathological endogenous alpha-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Reports. 2018;10(2):356–365.
   PubMed Web of Science ®Google Scholar
• Song YJ, Lundvig DM, Huang Y, et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol. 2007;171(4):1291–1303.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol. 2006;112(1):112.
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Stefanis L. alpha-Synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol. 2013;47(2):537–551.
   PubMed Web of Science ®Google Scholar
• Fouka M, Mavroeidi P, Tsaka G, et al. In search of effective treatments targeting alpha-synuclein toxicity in synucleinopathies: pros and cons. Front Cell Dev Biol. 2020;8:559791.
   PubMed Web of Science ®Google Scholar
• Stefanis L, Emmanouilidou E, Pantazopoulou M, et al. How is alpha-synuclein cleared from the cell? J Neurochem. 2019;150(5):577–590.
   PubMed Web of Science ®Google Scholar
• Lehotzky A, Tirian L, Tokesi N, et al. Dynamic targeting of microtubules by TPPP/p25 affects cell survival. J Cell Sci. 2004;117(25):6249–6259.
   PubMed Web of Science ®Google Scholar
• Lehotzky A, Olah J, Szunyogh S, et al. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome. Biochim Biophys Acta. 2015;1852(1):83–91.
   PubMed Web of Science ®Google Scholar
• Schwarz L, Goldbaum O, Bergmann M, et al. Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci. 2012;47(2):256–266.
   PubMed Web of Science ®Google Scholar
• Terni B, Rey MJ, Boluda S, et al. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol. 2007;113(4):403–416.
   PubMed Web of Science ®Google Scholar
• Tanji K, Odagiri S, Maruyama A, et al. Alteration of autophagosomal proteins in the brain of multiple system atrophy. Neurobiol Dis. 2013;49:190–198.
   PubMed Web of Science ®Google Scholar
• Odagiri S, Tanji K, Mori F, et al. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol. 2012;124:173–186.
   PubMed Web of Science ®Google Scholar
• Mori F, Nishie M, Piao YS, et al. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol. 2005;31:53–61.
   PubMed Web of Science ®Google Scholar
• Miki Y, Mori F, Tanji K, et al. Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology. 2011;31(6):561–568.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF. Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci. 2000;113(Pt 24):4441–4450.
   PubMed Web of Science ®Google Scholar
• Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432(7020):1032–1036.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889.
   PubMed Web of Science ®Google Scholar
• Biasini E, Fioriti L, Ceglia I, et al. Proteasome inhibition and aggregation in Parkinson’s disease: a comparative study in untransfected and transfected cells. J Neurochem. 2004;88(3):545–553.
   PubMed Web of Science ®Google Scholar
• Baba M, Nakajo S, Tu PH, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol. 1998;152:879–884.
   PubMed Web of Science ®Google Scholar
• Kumar ST, Jagannath S, Francois C, et al. How specific are the conformation-specific alpha-synuclein antibodies? Characterization and validation of 16 alpha-synuclein conformation-specific antibodies using well-characterized preparations of alpha-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Neurobiol Dis. 2020;146:105086.
   PubMed Web of Science ®Google Scholar
• Dice JF. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci. 1990;15(8):305–309.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Stefanis L, Fredenburg R, et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004;305:1292–1295.
   PubMed Web of Science ®Google Scholar
• Akaishi T, Yokosawa H, Sawada H. Regulatory subunit complex dissociated from 26S proteasome: isolation and characterization. Biochim Biophys Acta. 1995;1245:331–338.
   PubMed Web of Science ®Google Scholar
• Wheatley DN, Giddings MR, Inglis MS. Kinetics of degradation of “short-” and “long-lived” proteins in cultured mammalian cells. Cell biol int rep. 1980;4:1081–1090.
   PubMedGoogle Scholar
• Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci. 2017;18(9):1865.
   Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021;17:1–382.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Cuervo AM. Methods to monitor chaperone-mediated autophagy. Methods Enzymol. 2009;452:297–324.
   PubMed Web of Science ®Google Scholar
• Covell DJ, Robinson JL, Akhtar RS, et al. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson’s disease. Neuropathol Appl Neurobiol. 2017;43:604–620.
   PubMed Web of Science ®Google Scholar
• Ruesink H, Reimer L, Gregersen E, et al. Stabilization of alpha-synuclein oligomers using formaldehyde. PloS One. 2019;14:e0216764.
   PubMed Web of Science ®Google Scholar
• Pukass K, Richter-Landsberg C. Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular alpha-synuclein in oligodendrocytes. J Mol Neurosci. 2014;52:339–352.
   PubMed Web of Science ®Google Scholar
• Reyes JF, Rey NL, Bousset L, et al. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia. 2014;62(3):387–398.
   PubMed Web of Science ®Google Scholar
• Rockenstein E, Ubhi K, Inglis C, et al. Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy. Neuroreport. 2012;23(4):259–264.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Takei S, Kawamura N, et al. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy. Neuropathol Appl Neurobiol. 2012;38(6):559–571.
   PubMed Web of Science ®Google Scholar
• Makioka K, Yamazaki T, Takatama M, et al. Activation and alteration of lysosomes in multiple system atrophy. Neuroreport. 2012;23(5):270–276.
   PubMed Web of Science ®Google Scholar
• Monzio Compagnoni G, Kleiner G, Samarani M, et al. Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Reports. 2018;11(5):1185–1198.
   PubMed Web of Science ®Google Scholar
• Kaji S, Maki T, Ishimoto T, et al. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions. Transl Neurodegener. 2020;9(1):7.
   PubMed Web of Science ®Google Scholar
• Miki Y, Tanji K, Mori F, et al. AMBRA1, a novel alpha-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy. Brain Pathol. 2018;28:28–42.
   PubMed Web of Science ®Google Scholar
• Puska G, Lutz MI, Molnar K, et al. Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson’s disease and multiple system atrophy. Neurobiol Dis. 2018;114:140–152.
   PubMed Web of Science ®Google Scholar
• Fellner L, Buchinger E, Brueck D, et al. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived alpha-synuclein in oligodendroglia: implications for MSA pathogenesis. BMC Neurosci. 2018;19:32.
   PubMed Web of Science ®Google Scholar
• Pukass K, Goldbaum O, Richter-Landsberg C. Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of alpha-synuclein in oligodendroglial cells. J Neurochem. 2015;135:194–205.
   PubMed Web of Science ®Google Scholar
• Pukass K, Richter-Landsberg C. Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents alpha-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy. Front Cell Neurosci. 2015;9:163.
   PubMed Web of Science ®Google Scholar
• Spencer B, Valera E, Rockenstein E, et al. A brain-targeted, modified neurosin (kallikrein-6) reduces alpha-synuclein accumulation in a mouse model of multiple system atrophy. Mol Neurodegener. 2015;10:48.
   PubMed Web of Science ®Google Scholar
• Kiely AP, Miners JS, Courtney R, et al. Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of alpha-synuclein in multiple system atrophy. Neuropathol Appl Neurobiol. 2019;45:347–360.
   PubMed Web of Science ®Google Scholar
• Iwata A, Maruyama M, Akagi T, et al. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. Hum Mol Genet. 2003;12(20):2625–2635.
   PubMed Web of Science ®Google Scholar
• Stefanova N, Kaufmann WA, Humpel C, et al. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol. 2012;124:51–65.
   PubMed Web of Science ®Google Scholar
• Lehotzky A, Olah J, Fekete JT, et al. Co-transmission of alpha-synuclein and TPPP/p25 inhibits their proteolytic degradation in human cell models. Front Mol Biosci. 2021;8:666026.
   PubMed Web of Science ®Google Scholar
• Ejlerskov P, Rasmussen I, Nielsen TT, et al. Tubulin polymerization-promoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem. 2013;288:17313–17335.
   PubMed Web of Science ®Google Scholar
• Riedel M, Goldbaum O, Schwarz L, et al. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy. PLoS One. 2010;5:e8753.
   PubMed Web of Science ®Google Scholar
• Wu Y, Li X, Zhu JX, et al. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease. Neurosignals. 2011;19(3):163–174.
   PubMedGoogle Scholar
• Perez-Revuelta BI, Hettich MM, Ciociaro A, et al. Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis. 2014;5:e1209.
   PubMed Web of Science ®Google Scholar
• Malagelada C, Jin ZH, Jackson-Lewis V, et al. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson’s disease. J Neurosci. 2010;30:1166–1175.
   PubMed Web of Science ®Google Scholar
• Crews L, Spencer B, Desplats P, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PloS One. 2010;5:e9313.
   PubMed Web of Science ®Google Scholar
• Decressac M, Mattsson B, Weikop P, et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A. 2013;110:E1817–26.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Chigurupati S, Raymick J, et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson’s disease mouse model. Neurotoxicology. 2014;44:250–262.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Davies JE, Huang Z, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007;282:5641–5652.
   PubMed Web of Science ®Google Scholar
• Pupyshev AB, Tikhonova MA, Akopyan AA, et al. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson’s disease. Pharmacol Biochem Behav. 2019;177:1–11.
   PubMed Web of Science ®Google Scholar
• Pantazopoulou M, Brembati V, Kanellidi A, et al. Distinct alpha-synuclein species induced by seeding are selectively cleared by the lysosome or the proteasome in neuronally differentiated SH-SY5Y cells. J Neurochem. 2021;156(6):880–896.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Schapira AH, et al. Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson’s disease. Cell Death Dis. 2013;4:e545.
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Landeck N, et al. Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration. Brain. 2013;136(7):2130–2146.
   PubMedGoogle Scholar
• Richter-Landsberg C, Heinrich M. OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res. 1996;45(2):161–173.
   PubMed Web of Science ®Google Scholar
• McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980;85:890–902.
   PubMed Web of Science ®Google Scholar
• Bottenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci U S A. 1979;76:514–517.
   PubMed Web of Science ®Google Scholar
• Meng L, Mohan R, Kwok BH, et al. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A. 1999;96(18):10403–10408.
   PubMed Web of Science ®Google Scholar
• Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008;1:27–36.
   PubMedGoogle Scholar
• Anguiano J, Garner TP, Mahalingam M, et al. Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat Chem Biol. 2013;9:374–382.
   PubMed Web of Science ®Google Scholar
• Okerlund ND, Schneider K, Leal-Ortiz S, et al. Bassoon controls presynaptic autophagy through Atg5. Neuron. 2017;93:897–913 e7.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–24145.
   PubMed Web of Science ®Google Scholar
• Storrie B, Madden EA. Isolation of subcellular organelles. Methods Enzymol. 1990;182:203–225.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF, Knecht E. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem. 1997;272:5606–5615.
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Polissidis A, et al. Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy. 2016;12(11):2230–2247.
   PubMed Web of Science ®Google Scholar
• Emmanouilidou E, Stefanis L, Vekrellis K. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging. 2010;31(6):953–968.
   PubMed Web of Science ®Google Scholar
• Rukenstein A, Rydel RE, Greene LA. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci. 1991;11(8):2552–2563.
   PubMed Web of Science ®Google Scholar
• Farinelli SE, Greene LA, Friedman WJ. Neuroprotective actions of dipyridamole on cultured CNS neurons. J Neurosci. 1998;18(14):5112–5123.
   PubMed Web of Science ®Google Scholar
• Stefanis L, Park DS, Friedman WJ, et al. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J Neurosci. 1999;19(15):6235–6247.
   PubMed Web of Science ®Google Scholar
• Stefanis L, Troy CM, Qi H, et al. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J Neurochem. 1997;69(4):1425–1437.
   PubMed Web of Science ®Google Scholar
• Jakes R, Crowther RA, Lee VM, et al. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci Lett. 1999;269:13–16.
   PubMed Web of Science ®Google Scholar
• Iwatsubo T. Aggregation of alpha-synuclein in the pathogenesis of Parkinson’s disease. J Neurol. 2003;250(3):III11–4.
   PubMedGoogle Scholar
• Giasson BI, Jakes R, Goedert M, et al. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson’s disease. J Neurosci Res. 2000;59:528–533.
   PubMed Web of Science ®Google Scholar